<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="16956" whole_study_id="16956" phs="001002" v="1" p="1" createDate="2015-09-21T16:33:25-05:00" completedByGPADate="2015-09-25T16:53:21-05:00" modDate="2019-05-01T14:49:34-05:00" maxParentChildStudyModDate="2019-05-01T14:49:34-05:00" handle="CALGB90401_ProstateCancer" num_participants="810"><StudyInfo accession="phs001002.v1.p1" parentAccession="phs001002.v1.p1"><BioProject id="PRJNA298270" entrez_id="298270" type="bp_admin_access"/><BioProject id="PRJNA298271" entrez_id="298271" type="bp_data_submission"/><StudyNameEntrez>PGRN-RIKEN-CALGB 90401 - Genome-wide Pharmacogenomic Study of docetaxel and bevacizumab in Hormone Refractory Prostate Cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>germline</StudyType><StudyType>dna</StudyType><StudyType>snp_array</StudyType></StudyTypes><Funding>U01 GM063340</Funding></StudyInfo><Authority><ICs><IC id="1" name="NIGMS" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="HMCLEOD" aid="2" auth="eRA" login="HMCLEOD" fname="Howard" mname="L" lname="McLeod" email="howard.mcleod@moffitt.org"><Role>PI</Role><Organization>ORTELION, LLCWASHINGTON UNIVERSITYUNIV OF NORTH CAROLINA CHAPEL HILL</Organization></Person><Person nedid="0010150228" aid="1" auth="cit" login="dkras" fname="Donna" mname="M" lname="Krasnewich-Vostal" email="dkras@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Kouros" lname="Owzar" email="kouros.owzar@duke.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010150228" aid="1" auth="cit" login="dkras" fname="Donna" mname="M" lname="Krasnewich-Vostal" email="dkras@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>The investigators request that the following papers/abstracts are formally acknowledged.
Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, Morris M, Kantoff P, Monk JP, Kaplan E, Vogelzang NJ, Small EJ. Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401. J Clin Oncol. 2012 May 1;30(13):1534-40. PMID:22454414 Epub 2012 Mar 26.
Patel JN, Jiang C, Hertz DL, Mulkey FA, Owzar K, Halabi S, Ratain MJ, Friedman PN, Small EJ, Carducci MA, Mahoney JF, Kelley MJ, Morris MJ, Kelly WK, McLeod HL. Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer. 2015 Apr 1;121(7):1025-31. doi: 10.1002/cncr.29169. Epub 2014 Nov 21.

Hertz DL, Owzar K, Halabi S, Kelly WK, Zembutsu H, Jiang C, Patel JN, Watson D, Shterev I, Kroetz DL, Friedman PN, Mahoney JF, Carducci MA, Kelley MJ, Small EJ, Febbo PG, Nakamura Y, Kubo M, Ratain MJ, McLeod HL A genome-wide association study (GWAS) of docetaxel-induced peripheral neuropathy in CALGB 90401 (Alliance) 2013 ASCO Annual Meeting J Clin Oncol 31, 2013 (suppl; abstr 11053) 
 
Hertz DL, Jiang C, Owzar K, Halabi S,  Kelly WK, Mulkey F, Patel JN, Carducci MA,  Kelley MJ, Stadler WM, Mohamed MK, Morris MJ, Nakamura Y, Zembutsu H, Ratain MJ, McLeod HL. A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance) 2014 ASCO Annual Meeting   J Clin Oncol 32:5s, 2014 (suppl; abstr 9612)
</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="1752" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="58" dac_name="NIGMS" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>